Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Cerevel Therapeutics Holdings, Inc.

CERE•NASDAQ
Healthcare
Biotechnology
$44.96
$0.33(0.74%)
U.S. Market is Open • 12:26

Cerevel Therapeutics Holdings, Inc. (CERE) Stock Overview

Explore Cerevel Therapeutics Holdings, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap8.2B
P/E Ratio-16.83
EPS (TTM)$-2.73
ROE-0.72%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$58.57

CERE Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Cerevel Therapeutics Holdings, Inc. (CERE) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $58.57.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -16.83 and a market capitalization of 8.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
0.74%
3-Month Change
10.63%
6-Month Change
9.66%
Year-to-Date (YTD) Change
6.52%
1-Year Change
87.88%
3-Year Change
45.17%
5-Year Change
277.82%
All-Time (Max) Change
277.82%

Contact Information

https://www.cerevel.com
844 304 2048
222 Jacobs Street, Cambridge, MA, 02141

Company Facts

3,550 Employees
IPO DateJul 30, 2020
CountryUS

Frequently Asked Questions